BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 38538088)

  • 21. Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).
    Cao Y; Han D; Yang S; Shi Y; Zhao S; Jin Q; Li J; Li C; Zhang Y; Shen W; He J; Wang M; Ji G; Li Z; He Y; Chen Q; Wei W; Chen C; Gong X; Wang J; Tan L; Wang H; Li H
    BMC Cancer; 2022 Jun; 22(1):650. PubMed ID: 35698100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma.
    Liu J; Yang Y; Liu Z; Fu X; Cai X; Li H; Zhu L; Shen Y; Zhang H; Sun Y; Chen H; Yu B; Zhang R; Shao J; Zhang M; Li Z
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35338088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.
    Yang H; Liu H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Zhang X; Li Q; Wang G; Chen B; Mao T; Kong M; Guo X; Lin T; Liu M; Fu J
    JAMA Surg; 2021 Aug; 156(8):721-729. PubMed ID: 34160577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.
    Eyck BM; van Lanschot JJB; Hulshof MCCM; van der Wilk BJ; Shapiro J; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch OR; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Spillenaar Bilgen EJ; van der Sangen MJC; Rozema T; Ten Kate FJW; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A;
    J Clin Oncol; 2021 Jun; 39(18):1995-2004. PubMed ID: 33891478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
    Kelly RJ; Ajani JA; Kuzdzal J; Zander T; Van Cutsem E; Piessen G; Mendez G; Feliciano J; Motoyama S; Lièvre A; Uronis H; Elimova E; Grootscholten C; Geboes K; Zafar S; Snow S; Ko AH; Feeney K; Schenker M; Kocon P; Zhang J; Zhu L; Lei M; Singh P; Kondo K; Cleary JM; Moehler M;
    N Engl J Med; 2021 Apr; 384(13):1191-1203. PubMed ID: 33789008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN
    JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1).
    Li C; Zhao S; Zheng Y; Han Y; Chen X; Cheng Z; Wu Y; Feng X; Qi W; Chen K; Xiang J; Li J; Lerut T; Li H
    Eur J Cancer; 2021 Feb; 144():232-241. PubMed ID: 33373868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 30. Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma.
    Raja S; Rice TW; Murthy SC; Ahmad U; Semple ME; Blackstone EH; Ishwaran H;
    Ann Surg; 2021 Oct; 274(4):e320-e327. PubMed ID: 31850981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple, step-by-step guide to interpreting decision curve analysis.
    Vickers AJ; van Calster B; Steyerberg EW
    Diagn Progn Res; 2019; 3():18. PubMed ID: 31592444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How many lymph nodes should be dissected in esophagectomy with or without neoadjuvant therapy to get accurate staging?
    Zhan C; Shi Y; Jiang W; Sun F; Li M; Lu T; Yin J; Ma K; Yang X; Wang Q
    Dis Esophagus; 2020 Jan; 33(1):. PubMed ID: 30997490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer.
    Mariette C; Markar SR; Dabakuyo-Yonli TS; Meunier B; Pezet D; Collet D; D'Journo XB; Brigand C; Perniceni T; Carrère N; Mabrut JY; Msika S; Peschaud F; Prudhomme M; Bonnetain F; Piessen G;
    N Engl J Med; 2019 Jan; 380(2):152-162. PubMed ID: 30625052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial.
    van der Sluis PC; van der Horst S; May AM; Schippers C; Brosens LAA; Joore HCA; Kroese CC; Haj Mohammad N; Mook S; Vleggaar FP; Borel Rinkes IHM; Ruurda JP; van Hillegersberg R
    Ann Surg; 2019 Apr; 269(4):621-630. PubMed ID: 30308612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.
    Yang H; Liu H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Lordick F; D'Journo XB; Cerfolio RJ; Korst RJ; Novoa NM; Swanson SJ; Brunelli A; Ismail M; Fernando HC; Zhang X; Li Q; Wang G; Chen B; Mao T; Kong M; Guo X; Lin T; Liu M; Fu J;
    J Clin Oncol; 2018 Sep; 36(27):2796-2803. PubMed ID: 30089078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis.
    Visser E; Markar SR; Ruurda JP; Hanna GB; van Hillegersberg R
    Ann Surg; 2019 Feb; 269(2):261-268. PubMed ID: 29794846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Visser E; van Rossum PSN; Ruurda JP; van Hillegersberg R
    Ann Surg; 2017 Nov; 266(5):863-869. PubMed ID: 28742691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial.
    Stahl M; Walz MK; Riera-Knorrenschild J; Stuschke M; Sandermann A; Bitzer M; Wilke H; Budach W
    Eur J Cancer; 2017 Aug; 81():183-190. PubMed ID: 28628843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prognostic nomogram for overall survival after neoadjuvant radiotherapy or chemoradiotherapy in thoracic esophageal squamous cell carcinoma: a retrospective analysis.
    Deng W; Wang Q; Xiao Z; Tan L; Yang Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Li Y; He J; Gao S; Sun K; Cheng G; Liu X; Fang D; Xue Q; Mao Y; Wang D; Li J
    Oncotarget; 2017 Jun; 8(25):41102-41112. PubMed ID: 28456788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.